Therefore, this study aimed to assess the ECM of pancreatic cancer using the fECV derived from enhanced CT images and integrating fECV with α‐SMA‐positive CAFs and FAP‐positive CAFs to investigate their relation to clinicopathological characteristics and prognosis in patients with PDAC. The gene discussed is FAP; the disease is familial pancreatic carcinoma.